Cna Financial Corp Repligen Corp Transaction History

Cna Financial Corp

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	SELL	$160.42 - $256.21 $320,840 - $512,419	-2,000 Reduced 42.01%	2,761 $517,000
Q2 2022 Aug 09, 2022	SELL	$140.68 - $188.02 $49,238 - $65,807	-350 Reduced 6.85%	4,761 $773,000
Q1 2022 May 10, 2022	BUY	$161.19 - $257.96 $159,578 - $255,380	990 Added 24.02%	5,111 $961,000
Q4 2021 Feb 11, 2022	SELL	$247.59 - $304.47 $153,505 - $188,771	-620 Reduced 13.08%	4,121 $1.09 Million
Q3 2021 Nov 12, 2021	SELL	$194.77 - $324.21 $44,797 - $74,568	-230 Reduced 4.63%	4,741 $1.37 Million
Q2 2021 Aug 12, 2021	BUY	$165.87 - $220.95 $28,197 - $37,561	170 Added 3.54%	4,971 $992,000
Q1 2021 May 14, 2021	BUY	$180.37 - $226.26 $25,251 - $31,676	140 Added 3.0%	4,801 $933,000
Q4 2020 Feb 12, 2021	SELL	$148.08 - $206.57 $4,442 - $6,197	-30 Reduced 0.64%	4,661 $893,000
Q3 2020 Nov 12, 2020	SELL	$122.51 - $158.27 $120,059 - $155,104	-980 Reduced 17.28%	4,691 $692,000
Q2 2020 Aug 13, 2020	BUY	$94.33 - $140.48 $534,945 - $796,662	5,671 New	5,671 $701,000

488

54.2M

341K

235K

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $8.02B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

Get notified when there are updates to the investment portfolio of Cna Financial Corp, based on Form 13F filings with the SEC.

Stay updated on Cna Financial Corp with notifications on news.